THSSKS
Posted - 3 days ago
$HLVX 180m cash. 90m mkt cap. Scrap the science projects and send this to the moon 🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀
approved_13
Posted - 1 week ago
$HLVX can someone tell me if they are going through phase 3 or not and when?
TrendSetter67
Posted - 1 week ago
$VXRT This, I believe, is an extremely relevant observation. $HLVX Phase 2 Norovirus failure can be related to thinking that histo-blood group antigen (HBGA) blocking antibody is the key to efficacy for this enteric disease. But in field testing, it failed even with HBGA boosted values. $MRNA is on the same track of progressing their Noro candidate into Phase 3 using elevated HBGA values as the driver. But, Vaxart's human challenge trial has determined that the Correlates of Protection (CoPs) are not governed by HBGA, but rather actual serum antibodies AND Fecal IgA. Is Moderna also on a fool's fast track like Hillevax? Both are Injectables trying to prevent a Disease of the GUT only using HBGA (which is serum-based indirect measure of antibodies).
TrendSetter67
Posted - 1 week ago
$HLVX is now a Zombie company whose only asset is cash. The fact that they can offer no info in their Q3 ER on their only remaining Noro trial (adult) after shutting down the infant one( showing 5% efficacy), while outwardly pursuing strategic options is all one needs to know that their Takeda spin-off vaccine is a dud. But this was easily deducted from years ago with their human challenge trial poor results. Once $VXRT blew them away in all measures with their own, more aggressive HCT last year, anyone who stayed long in the jab has paid a heavy financial price.
Watch for a Vaxart huge pps run once they gain agreement from the FDA to run their late phase Noro trials tailored as small, compact, HCT-based and of CoPs deterministic design to calculate real world efficacy instead of the typical large random field trial sites that does nothing but return unrealistic results at high cost.
While the BARDA is funding our VAAST pill platform validation, the pps FOMO will be via Noro.
smartkarma
Posted - 2 weeks ago
$HLVX | HilleVax Strategic Review: Cash Position, Workforce Reductions, and Potential Strategic Alternatives
"HilleVax trades at a 46% discount to net cash, with potential upside from strategic review outcomes like liquidation or sale." - Dalius Tauraitis (Special Situation Investments)
Read more: https://www.smartkarma.com/insights/hillevax-strategic-review-cash-position-workforce-reductions-and-potential-strategic-alternatives
approved_13
Posted - 10/29/24
$HLVX
approved_13
Posted - 1 month ago
$HLVX it’s buy #2 now
approved_13
Posted - 1 month ago
$HLVX it’s time baby it’s time
joe77w
Posted - 1 month ago
$HLVX I Hope Tang increasing share or launch take over, stock too cheap imo.
joe77w
Posted - 1 month ago
$HLVX It should deserve 4/5 USD alone for cash position
approved_13
Posted - 1 month ago
$HLVX that’s what we want here
approved_13
Posted - 1 month ago
$HLVX when this will be on the moon?
TrendSetter67
Posted - 1 month ago
$VXRT $HLVX $MRNA I stand by this and I am looking forward to the Vaxart IDWeek presentation tomorrow that covers both their Noro pill data for Adults and Infants (via the innoculated Mother's Breastmilk protective transfer).
joe77w
Posted - 1 month ago
$KZR $ALXO $HLVX HLVX May be next take over target, too cheap
joe77w
Posted - 1 month ago
$HLVX https://fintel.io/doc/sec-tang-capital-partners-lp-1888012-sc-13g-2024-july-23-19927-5162
Tang owns 9.5% May Bid for GLVX given It Is plenty of cash and trading at huge discount to net cash, Just my opinion
TrendSetter67
Posted - 1 month ago
$VXRT Remember $HLVX and their Noro vaccine 5% efficacy? Injectables just do not work against enteric viruses. Thus, while Moderna is pushing fast and hard with their own Noro jab, I am not concerned that their money and influence will likely give them 1st entry to market with a substandard product.
But, I do want to see Vaxart make a firm commitment very soon on their path forward. We have lost 1 year in the Noro race with their FDA negotiations....yes, it's been 1 year already since the HCT results showed we blew away Hillevax's candidate.
"The virus-like particle-based vaccine, dubbed HIL-214, missed all primary and secondary endpoints of the NEST-IN1 study of more than 2,800 infants aged about five months of age in the U.S. and Latin America.
The vaccine showed an efficacy of 5%, with 51 primary endpoints among the 1,425 infants who received HIL-214 and 25 of these endpoints among the 1,399 infants who received placebo."
stonkystonks8520
Posted - 1 month ago
$HLVX
MadHatterTrades74
Posted - 1 month ago
$KZR Tang Capital up to his usual shenanigans. He continues to make lowball bids on depressed stocks. He has only succeeded in doing this once in the past three years. This company has a price per share ratio of $2.25 so is highly unlikely that the board will accept his proposal. he has also taken a 9.5% stake in two other companies in the last two months. $HLVX & $ALXO these have not received takeover bids, but are very much trading below cash, so we will see
Dozierdd
Posted - 1 month ago
$HLVX possible move here?
Hass19
Posted - 1 month ago
$HLVX wtf This stock been stuck for over a month
SamGantVHee
Posted - 09/29/24
$HLVX 🤔looks good for an add
Hass19
Posted - 09/26/24
$HLVX
hitmongreen
Posted - 2 months ago
$HLVX
TheBattleDude
Posted - 2 months ago
$HLVX this has been amazing for trading in range! now lets see some real movement!
DougieFreshPicks
Posted - 2 months ago
$HLVX it wants to curl up and the bottom is around $1.69 so watch for any dips!!!
Hass19
Posted - 2 months ago
$HLVX 🚀🚀🚀
hitmongreen
Posted - 2 months ago
$HLVX 🧐
TheBattleDude
Posted - 2 months ago
$HLVX ok this is going to 1.60ish which I will once again buy and sell at 2 lol
TheBattleDude
Posted - 2 months ago
$HLVX This stock is good for playing the range that is 1.60 bump to 2.00 I like this stocks bumps and lumps